The Medication(s) listed below have been approved by the Food & Drug Administration (FDA) as orphan products for treatment of this condition. There may be other products available
that are not considered orphan products.
Alpha1-Proteinase Inhibitor (Human) (Brand name: Prolastin)
- Manufactured by
Grifols United States
FDA-approved indication: For chronic replacement therapy of individuals having congenital deficiency of alpha1- proteinase inhibitor with clinically demonstrable panacinar emphysema.
National Library of Medicine Drug Information Portal